55,057 Shares in Astera Labs, Inc. $ALAB Bought by Granahan Investment Management LLC

Key Points

• Granahan Investment Management LLC acquired 55,057 shares of Astera Labs, Inc., valued at approximately $3.3 million, indicating growing institutional interest in the company.
• Astera Labs CEO Jitendra Mohan sold 91,441 shares for around $16.78 million, leading to a 4.04% reduction in his ownership position.
• The company reported impressive earnings with a revenue increase of 149.5% year-over-year and EPS of $0.44, surpassing analyst expectations.

Granahan Investment Management LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 55,057 shares of the company's stock, valued at approximately $3,285,000.

Other large investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in shares of Astera Labs by 4.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 18,250 shares of the company's stock worth $2,417,000 after purchasing an additional 768 shares in the last quarter. Northern Trust Corp grew its stake in Astera Labs by 257.7% during the 4th quarter. Northern Trust Corp now owns 296,120 shares of the company's stock worth $39,221,000 after buying an additional 213,343 shares during the last quarter. Cetera Investment Advisers purchased a new position in Astera Labs during the 4th quarter worth approximately $460,000. Cresset Asset Management LLC acquired a new position in Astera Labs during the fourth quarter worth approximately $216,000. Finally, Deutsche Bank AG lifted its stake in Astera Labs by 33.0% in the fourth quarter. Deutsche Bank AG now owns 7,695 shares of the company's stock valued at $1,019,000 after buying an additional 1,909 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of Astera Labs stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $188.70, for a total value of $1,887,000.00. Following the transaction, the general counsel directly owned 161,573 shares of the company's stock, valued at approximately $30,488,825.10. This trade represents a 5.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,832,489 shares of company stock valued at $264,172,396 over the last 90 days. Insiders own 12.50% of the company's stock.

Astera Labs Stock Performance

Shares of ALAB opened at $191.20 on Friday. The stock has a market capitalization of $31.78 billion, a P/E ratio of 341.43, a P/E/G ratio of 4.77 and a beta of 1.48. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The company's fifty day moving average is $141.64 and its two-hundred day moving average is $98.87.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business's revenue was up 149.5% on a year-over-year basis. During the same quarter last year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Needham & Company LLC increased their price objective on Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Barclays reiterated an "overweight" rating and issued a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Northland Capmk downgraded shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 22nd. CICC Research initiated coverage on shares of Astera Labs in a research note on Friday, August 29th. They issued an "outperform" rating and a $190.00 price objective on the stock. Finally, Evercore ISI increased their target price on shares of Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $142.00.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.